Dioralyte Rebalance Blackcurrant Powder for Oral Solution. *
Company:
SANOFIStatus:
No Recent UpdateLegal Category:
Supply through pharmacy onlyActive Ingredient(s):
*Additional information is available within the SPC or upon request to the company
When a pharmaceutical company changes any document, a new version is published on medicines.ie. For each version, we show the dates it was published on medicines.ie and the reasons for change.
Updated on 13 May 2021
File name
Dioralyte Rebalance patient leaflet IE1160 cropped_1620924193.pdf
Reasons for updating
- Change to section 2 - use in children and adolescents
- Change to section 3 - dose and frequency
- Change to section 3 - use in children/adolescents
- Change to section 3 - how to take/use
- Change to section 3 - duration of treatment
- Change to section 4 - how to report a side effect
- Change to section 6 - date of revision
Updated on 13 May 2021
File name
1.3.1 SmPC Dioralyte Rebalance Blackcurrant_1620923842.pdf
Reasons for updating
- Change to section 4.1 - Therapeutic indications
- Change to section 4.2 - Posology and method of administration
- Change to Section 4.8 – Undesirable effects - how to report a side effect
- Change to section 10 - Date of revision of the text
Legal category:Supply through pharmacy only
Updated on 19 March 2020
File name
1.3.1 SmPC Dioralyte Rebalance Blackcurrant_1584634859.pdf
Reasons for updating
- New SPC for new product
Legal category:Supply through pharmacy only
Updated on 19 March 2020
File name
Dioralyte Rebalance PL 419521_1584634841.pdf
Reasons for updating
- New PIL for new product